A Randomized, Multicenter, Phase III Trial of Tacrolimus/Methotrexate versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation

Brief Summary

Type:
Leukemias

Study Type:
Prevention

Phase:
III

ClinicalTrials.gov Identifier:
NCT03959241

Study #:
STUDY00144070

Start Date:
Dec 22, 2019

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03959241

View Complete Trial Details & Eligibility at ClinicalTrials.gov